Pleural Effusion Occurring During Lung Cancer Immunotherapy: A Challenge for the Clinician

Roussel, Lucile; Brindel, Aurélien; Pouget, Celsio; Treffel, Gauthier; Billon, Yves; Vaillant, Pierre; Tiotiu, Angelica.
Arch. bronconeumol. (Ed. impr.) ; 58(2): 194-196, feb. 2022. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-203041

Documentos relacionados

  1. Proteomics: A new dimension to decode small cell lung cancer.
  2. Single-cell RNA sequencing reveals immune microenvironment of small cell lung cancer-associated malignant pleural effusion.
  3. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
  4. Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
  5. Advancements in small cell lung cancer.
  6. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
  7. Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territory.
  8. Identification of natural compounds tubercidin and lycorine HCl against small-cell lung cancer and BCAT1 as a therapeutic target.
  9. Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.
  10. Holistic immunomodulation for small cell lung cancer.